Spots Global Cancer Trial Database for MRI- Guided Transurethral Ultrasound Ablation of Localized Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: MRI- Guided Transurethral Ultrasound Ablation of Localized Prostate Cancer
Official Title: Evaluation of an Alternative Treatment of Localized Prostate Cancer by Guided MRI Transurtral Ultrasound With 1-year Control of the Absence of Cancer
Study ID: NCT03996005
Study Description
Brief Summary: Primary purpose : Evaluation of the efficiency and safety of an alternative global prostate treatment in localized prostate cancer. Primary Objective: Absence of clinically significant cancer (CSC) on control biopsy at 1-year follow-up. Secondary Objectives: 1. Biochemical response 2. Presence of any CSC on biopsy at 1- and 2-year follow-up 3. Radical treatment free survival 4. Adverse events, clinical tolerance 5. Urinary continence 6. Erectile function 7. Quality of life
Detailed Description:
Keywords
Eligibility
Minimum Age: 80 Years
Eligible Ages: OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Hôpitaux Universitaires de strasbourg, Strasbourg, , France
Contact Details
Name: Thibault TRICARD, MD
Affiliation: University Hospital, Strasbourg, France
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
